William G. Gerber
Algemeen Directeur bij SynGen, Inc.
Profiel
William G.
Gerber currently works at SynGen, Inc., as Chairman, President & Chief Executive Officer, Pathway Diagnostics Corp., as Chairman, and Radiant Medical, Inc., as Director.
Dr. Gerber also formerly worked at Epoch Biosciences, Inc., as President & Chief Executive Officer from 1999 to 2004, diaDexus, Inc., as President & Chief Executive Officer from 1998 to 1999, Ngen, Inc., as Director from 2005 to 2007, Sangamo Therapeutics, Inc., as Director from 1997 to 2011, Gentiae Clinical Research, Inc., as Director, Aviir, Inc., as Director, Conatus Pharmaceuticals, Inc., as Director, Vivaldi Biosciences, Inc., as Director, Nexus Dx, Inc., as Director, ITC Nexus Holding Co., Inc., as Director, Galileo Pharmaceuticals, Inc., as Director, NABsys, Inc., as Director, Fabric Genomics, Inc., as Director, Onyx Pharmaceuticals, Inc., as Chief Operating Officer & Vice President, Chiron Diagnostics Corp., as President, Cetus Corp., as VP & GM-Polymerase Chain Reaction Division from 1987 to 2010, State of California, as President-Medical Quality Assurance Board, and Bay City Capital LLC, as Advisor.
Dr. Gerber received his undergraduate degree and doctorate degree from The University of California, San Francisco.
Actieve functies van William G. Gerber
Bedrijven | Functie | Begin |
---|---|---|
Radiant Medical, Inc.
Radiant Medical, Inc. Pharmaceuticals: MajorHealth Technology Radiant Medical, Inc. develops and manufactures endovascular temperature therapy products. Its products are used for the treatment of radiocontrast nephropathy, heart attack, and cardiac arrest. The company was founded in 1997 and is located in Redwood City, CA. | Directeur/Bestuurslid | - |
Pathway Diagnostics Corp.
Pathway Diagnostics Corp. Medical SpecialtiesHealth Technology Pathway Diagnostics Corp. develops biomedical and biomarker products. It develops biomarkers of disease into novel esoteric tests. The company specializes in the identification, optimization & validation of biomarker assays for all phases of drug development and clinical diagnostic applications makes them a valuable partner for pharmaceutical & biotechnology companies. Pathway Diagnostics is headquartered in Malibu, CA. | Voorzitter | - |
SynGen, Inc.
SynGen, Inc. Electronic Equipment/InstrumentsElectronic Technology SynGen, Inc. designs and manufactures innovative devices designed for separation and isolation of therapeutic cells. It offers products that improve the recovery, purity and viability of stem and other clinically important cells from umbilical cord blood, peripheral blood, bone marrow, and cell culture. The firms products include SynGenX-1000 System, CryoPRO-2 Bag Sets, SynGenX-LAB System, and tube welding workstation. The company was founded by Philip H. Coelho, Gabriel G. Alvarado, and George J. Barry in 1999 and is headquartered in Rancho Cordova, CA | Algemeen Directeur | - |
Eerdere bekende functies van William G. Gerber
Bedrijven | Functie | Einde |
---|---|---|
ITC Nexus Holding Co., Inc.
ITC Nexus Holding Co., Inc. Medical SpecialtiesHealth Technology ITC Nexus Holding Co., Inc. is a hospital-focused point-of-care (POC) cardiovascular diagnostics company. It is primarily focused on the manufacture and sale of testing equipment and associated disposables used to measure blood coagulation and platelet response. The company’s two lead products are the Hemochron and VerifyNow systems. Hemochron is used by physicians during cardiovascular interventions to monitor a patient’s blood clotting factors. VerifyNow is used to measure platelet reactivity following antiplatelet therapies, including ADP receptor antagonists and aspirin. | Directeur/Bestuurslid | 21-05-2014 |
Aviir, Inc.
Aviir, Inc. Medical/Nursing ServicesHealth Services Aviir, Inc. discovers, develops and commercializes diagnostic laboratory tests for cardiovascular diseases. The biotechnology company specializes in developing proprietary diagnostic tests to assist in identifying patients who are truly at high risk for the development of a cardiac event. The company was founded in 2005 and is headquartered in Irvine, CA. | Directeur/Bestuurslid | 16-04-2014 |
HISTOGEN INC. | Directeur/Bestuurslid | 01-06-2013 |
Gentiae Clinical Research, Inc.
Gentiae Clinical Research, Inc. Medical/Nursing ServicesHealth Services Gentiae Clinical Research, Inc. provides cardiovascular laboratory services to the pharmaceutical, biotechnology, and medical device companies. It provides cardiac safety monitoring, core laboratory, data management, and global logistic services to support clinical trials. The company was founded in 2001 and is headquartered in San Bruno, CA. | Directeur/Bestuurslid | 28-09-2009 |
NGEN INC | Directeur/Bestuurslid | 01-05-2007 |
Opleiding van William G. Gerber
The University of California, San Francisco | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SANGAMO THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 20 |
---|---|
Epoch Biosciences, Inc.
Epoch Biosciences, Inc. Medical SpecialtiesHealth Technology Epoch Biosciences, Inc. manufactures and develops molecular tools for genetic analysis. Its technology has numerous applications including the detection of inherited diseases and single nucleotide polymorphisms to identify individuals at risk for disease or adverse drug reactions and gene expression measurement. The company was founded in 1985 and is headquartered in Bothell, WA. | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Health Technology |
Ngen, Inc.
Ngen, Inc. Medical SpecialtiesHealth Technology Ngen, Inc. advanced diagnostics provides physicians and patients worldwide with sophisticated information to predict, diagnose and treat disease. Research and clinical reference labs use the highly accurate and reliable NanoChip(R) Molecular Biology Workstation, NanoChip(R) Electronic Microarray and broad suite of analyte specific reagents to develop diagnostic tests for variety of diseases. Nanogen also offers a broad portfolio of patented nucleic acids chemistries and molecular tools that accelerate genomic analysis and are compatible with many systems. The SynX subsidiary offers a line of point-of-care diagnostic tests and is building expertise in cardiac related health conditions. Nanogen's ten years of pioneering research involving nanotechnology may also have future applications in medical diagnostics, biowarfare and other industries. The company is headquartered in San Diego, CA | Health Technology |
Radiant Medical, Inc.
Radiant Medical, Inc. Pharmaceuticals: MajorHealth Technology Radiant Medical, Inc. develops and manufactures endovascular temperature therapy products. Its products are used for the treatment of radiocontrast nephropathy, heart attack, and cardiac arrest. The company was founded in 1997 and is located in Redwood City, CA. | Health Technology |
Bay City Capital LLC
Bay City Capital LLC Investment ManagersFinance Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States. | Finance |
Pathway Diagnostics Corp.
Pathway Diagnostics Corp. Medical SpecialtiesHealth Technology Pathway Diagnostics Corp. develops biomedical and biomarker products. It develops biomarkers of disease into novel esoteric tests. The company specializes in the identification, optimization & validation of biomarker assays for all phases of drug development and clinical diagnostic applications makes them a valuable partner for pharmaceutical & biotechnology companies. Pathway Diagnostics is headquartered in Malibu, CA. | Health Technology |
Conatus Pharmaceuticals, Inc.
Conatus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active selective caspase inhibitor, for diseases involving inflammasome pathways. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA. | Health Technology |
Gentiae Clinical Research, Inc.
Gentiae Clinical Research, Inc. Medical/Nursing ServicesHealth Services Gentiae Clinical Research, Inc. provides cardiovascular laboratory services to the pharmaceutical, biotechnology, and medical device companies. It provides cardiac safety monitoring, core laboratory, data management, and global logistic services to support clinical trials. The company was founded in 2001 and is headquartered in San Bruno, CA. | Health Services |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | Health Technology |
Aviir, Inc.
Aviir, Inc. Medical/Nursing ServicesHealth Services Aviir, Inc. discovers, develops and commercializes diagnostic laboratory tests for cardiovascular diseases. The biotechnology company specializes in developing proprietary diagnostic tests to assist in identifying patients who are truly at high risk for the development of a cardiac event. The company was founded in 2005 and is headquartered in Irvine, CA. | Health Services |
Cetus Corp. | Health Technology |
Galileo Pharmaceuticals, Inc.
Galileo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galileo Pharmaceuticals, Inc. develops therapeutics and pharmaceuticals for redox failure such as stroke, heart attack, and diabetes. It also owns and operates laboratories. The company was founded by Dr. Guy Miller in 1998 and is headquartered in Santa Clara, CA. | Health Technology |
Vivaldi Biosciences, Inc.
Vivaldi Biosciences, Inc. Drugstore ChainsRetail Trade Vivaldi Biosciences Inc. develops and markets vaccines. It specializes in developing live attenuated influenza vaccines (LAIVs). The company was founded by Eliott Kieff, Peter Palese, and Adolfo García-Sastre in 2006 and is headquartered in Fort Collins, CO. | Retail Trade |
Nexus Dx, Inc.
Nexus Dx, Inc. Medical/Nursing ServicesHealth Services Nexus Dx, Inc. engages in the provision of of a near patient testing system and advanced diagnostic solution. Its offers point-of-care (POC) immunoassay, IB10 analyzer system, and tests for established critical care parameters. The company was founded on January 16, 2009 and is headquartered in San Diego, CA. | Health Services |
ITC Nexus Holding Co., Inc.
ITC Nexus Holding Co., Inc. Medical SpecialtiesHealth Technology ITC Nexus Holding Co., Inc. is a hospital-focused point-of-care (POC) cardiovascular diagnostics company. It is primarily focused on the manufacture and sale of testing equipment and associated disposables used to measure blood coagulation and platelet response. The company’s two lead products are the Hemochron and VerifyNow systems. Hemochron is used by physicians during cardiovascular interventions to monitor a patient’s blood clotting factors. VerifyNow is used to measure platelet reactivity following antiplatelet therapies, including ADP receptor antagonists and aspirin. | Health Technology |
NABsys, Inc.
NABsys, Inc. Miscellaneous Commercial ServicesCommercial Services NABsys, Inc. developed DNA analysis sequencing platform. Its platform used solid-state nanodetectors to analyze single DNA molecules, revealing both location and identity of DNA sequences over long distances. The firm system was designed to set new standards for accuracy, speed and scalability, offering compelling advantages for the analysis of genome structural variation, genome mapping, and both targeted and whole genome sequencing. The company was founded by Xinsheng Sean Ling, Leon N. Cooper and Barrett Bready in 2004 and was headquartered in Providence, RI. | Commercial Services |
Fabric Genomics, Inc.
Fabric Genomics, Inc. Packaged SoftwareTechnology Services Fabric Genomics, Inc. operates as an analytical genome interpretation company. It develops scalable and fully integrated informatics systems specifically design to interpret human genome sequences for research and clinical applications. The company was founded by by Martin G. Reese, Edward S. Kiruluta, John Stuelpnagel, and Paul Billings and is headquartered in Oakland, CA. | Technology Services |
SynGen, Inc.
SynGen, Inc. Electronic Equipment/InstrumentsElectronic Technology SynGen, Inc. designs and manufactures innovative devices designed for separation and isolation of therapeutic cells. It offers products that improve the recovery, purity and viability of stem and other clinically important cells from umbilical cord blood, peripheral blood, bone marrow, and cell culture. The firms products include SynGenX-1000 System, CryoPRO-2 Bag Sets, SynGenX-LAB System, and tube welding workstation. The company was founded by Philip H. Coelho, Gabriel G. Alvarado, and George J. Barry in 1999 and is headquartered in Rancho Cordova, CA | Electronic Technology |
Chiron Diagnostics Corp.
Chiron Diagnostics Corp. Medical SpecialtiesHealth Technology Part of Bayer AG, Chiron Diagnostics Corp. is a company that develops medical diagnostic products. The company is based in East Walpole, MA. Chiron Diagnostics was acquired by Bayer AG from Chiron Corp. on November 30, 1998 for $1,100 million. | Health Technology |
State of California | Government |